Solubility and bioavailability improvement of Glcclazide by solid dispersions using novel carriers

International Journal of Drug Delivery

Volumn 4, Issue 4, 2012, Pages 455-461

  Devireddy, Srinivas Reddy ^a   Veerareddy, Prabhakar Reddy ^b  

^a Vaageswari Institute of Pharmaceutical Sciences   (India)

^b Chaitanya College of Pharmacy Education and Research   (India)

Author keywords

Bioavailability; Fusion; Gelucires; Solid dispersion; Vitamin E TPGS

Indexed keywords

ALPHA TOCOPHEROL; GELUCIRE; GLICLAZIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG SOLUBILITY; HYDROPHOBICITY; IN VIVO STUDY; MALE; NONHUMAN; PH MEASUREMENT; PROCESS DEVELOPMENT; RABBIT; SOLID DISPERSION; STOMACH ABSORPTION; TABLET FORMULATION; X RAY DIFFRACTION;

EID: 84886081436     PISSN: None     EISSN: 09750215     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gillmann AG, Rall TW, Nies AS, Taylor P, In: Goodman and Gillmann's The Pharmacological Basis Therapeutics. 8th ed., Pergamon, Maxwell House, New York, U.S. A, 1990; 1485-1486.
2. Chawdhary KPR, Vijayasrinivas S. Biopharmaceutical classification system. Indian Pharmacist 2004; 2: 7-10.
3. Vikas S, Vipin K, Mahesh K, Manoj G, Pratim C. Dissolution Enhancement of Drugs. Part I: Technologies and Effect of Carriers. International Journal of Health Research 2009; 2 (2): 107-124.
4. Overhoff KA, Engstrom JD, Chen B. Novel ultra rapid freezing particle engineering process for enhancement of dissolution rates of poorly water soluble drugs. Eur J Pharm Biopharm 2007; 65: 57-67.
5. Ahuja N, Katare OP, Singh B. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm 2007; 65: 26-38.
6. Friedrich H, Fussnegger B, Kolter K, Bodmeier R. Dissolution rate improvement of poorly water soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers. Eur J Pharm Biopharm 2006; 62: 171-177.
7. Varshosaz J, Talari R, Mostafavi SA, Nokhodchi A. Dissolution enhancement of Glcclazide using in situ micronization by solvent change method. Powder Technology 2008; 187(3): 222-230.
8. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000; 50: 47-60.
9. Duncan QMC. The mechanism of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2002; 231: 131-144.
10. Sharma DK, Joshi SB. Solubility enhancement strategies for poorly water-soluble drugs in solid dispersions. Asian journal of Pharmaceutics 2007; 1(1): 9-14.
11. Asyarie S, Rachmawati H. In vivo and in vitro evaluation of a solid dispersion system of Glcclazide: PEG 6000. PDA J Pharm Sci Technol 2007; 61(5): 400-410.
12. Neelam S, Mamta K. Micellar Solubilization of Some Poorly Soluble Anti diabetic Drugs: A Technical Note. AAPS Pharm Sci Tech 2008; 9(2): 431-436
13. Khouloud AA, Hussien A, Wafaa YA. Study of the solubilisation of Glcclazide by aqueous micellar solutions. Journal of Pharmaceutical Sciences 2003; 92(4): 839-846.
14. Aggarwal S, Singh PN, Mishra B. Studies on solubility and hypoglycemic activity of Glcclazide betacyclodextrinhydroxypropylmethy l cellulose complexes. Pharmazie 2002; 57: 191-203.
15. Hiremath SN, Raghavendra RK, Sunil F, Danki LS, Rampure MV, Swamy PV, Bhosale UV. Dissolution enhancement of Glcclazide by preparation of inclusion complexes with β-cyclodextrin. Asian journal of Pharmaceutics 2008; 2(1): 73-76.
16. Patil MP, Naresh GJ. Preparation and characterization of Glcclazide-polyethylene glycol 4000 solid dispersions. Acta Pharm 2009; 59: 57-65.
17. Biswal S, Sahoo J, Murthy PN, Giradkar RP, Avari JG. Enhancement of Dissolution Rate of Glcclazide Using Solid Dispersions with Polyethylene Glycol 6000. AAPS Pharm Sci Tech 2008; 8 (4) Article 108: E1-E8.
18. Betageri GV, Makarla KR. Enhancement of dissolution of glyburide by solid dispersion and lyophillisation techniques. Int J Pharm 1995; 126: 155-160.
19. Higuchi T, Connors KA. Phase solubility Techniques. Adv Anal Chem Instrum 1965; 4: 117-212.
20. Serajuddin, A.T.M., Solid dispersions of poorly watersoluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 1999: 88; 1058-1066.
21. Khoo, S.M., Porter, C.J.H., Charman, W.N. The formulation of halofantrine as either nonsolubilising PEG 6000 or solubilising lipid based solid dispersions: physical stability and absolute bioavailability assessment. Int. J. Pharm. 2000; 205, 65-78.
22. Bhaskar Chauhan, Shyam Shimpi, Anant Paradkar, Preparation and evaluation of Glcbenclamide solid dispersions with silicone dioxide by spray drying technique. Eur J Pharm Sci 2005;26: 219-230.
23. Sethia S, Squillante E, Solid dispersion of carbamazepine in pvp k30 by conventional solvent evaporation and supercritical methods. Int. J. of Pharm., 2004;272:1-10.
24. Farzana S. Bandarkar, Ibrahim S. Khattab, lyophilized Glcclazidepoloxamersolid dispersions for enhancement of invitro dissolution and invivo bioavailability international journal of pharmacy and pharmaceutical sciences, 2011, 3 (2).
25. Hisham S. Abou-Auda, Saleh A. Bawazir, Yousef A. Asiri, Studies on solubility and hypoglycemic activity of Glcclazide B-cyclodextrin complexes, International Journal of Pharmacology, 2006:\; 2 (6):656-663.